FHTX
Foghorn Therapeutics
$5.20
+$0.35 (+7.22%)Jul 27, 2026
Key metrics
The numbers that frame FHTX today
- Market cap
- $305.31M
- P/E (TTM)
- -4.1
- EV / FCF
- -2.9
- Gross margin
- 100%
- EV / Sales
- 9.1
- ROIC
- -86%
- Div yield
- 0%
- 52wk Low
- $3.27
- 52wk High
- $6.95
Growth
Revenue and earnings trend for FHTX
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about FHTX
Is Foghorn Therapeutics a good buy?
No. Foghorn Therapeutics has weak quality and poor momentum. Both signals point to a weaker setup. Growth looks mixed. The support signal is useful, but not decisive. We think Foghorn Therapeutics is selling at a very high price.
What is the market capitalization of FHTX?
Foghorn Therapeutics's market capitalization is $305.31M.
What is the P/E ratio for FHTX stock?
Foghorn Therapeutics's current P/E ratio is -4.1.
What is the 52-week high for FHTX stock?
The 52-week high for Foghorn Therapeutics is $6.95. The current close of $5.20 is 25.2% below that high.
What is the 52-week low for FHTX stock?
The 52-week low for Foghorn Therapeutics is $3.27. The current close of $5.20 is 59% above that low.
Does FHTX stock pay dividends?
Foghorn Therapeutics does not currently show a dividend per share in the company data.